215 related articles for article (PubMed ID: 36882627)
21. The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial.
Wang X; Li S; Sun Y; Li K; Shen X; Xue Y; Liang P; Li G; Chen L; Zhao Q; Li G; Fu W; Liang H; Xin H; Suo J; Fang X; Zheng Z; Xu Z; Chen H; Zhou Y; He Y; Huang H; Zhu L; Yang K; Ji J; Ye Y; Zhang Z; Li F; Wang X; Tian Y; Park S; Chen L
BMC Cancer; 2021 Jan; 21(1):20. PubMed ID: 33402102
[TBL] [Abstract][Full Text] [Related]
22. A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer.
Anderson E; LeVee A; Kim S; Atkins K; Guan M; Placencio-Hickok V; Moshayedi N; Hendifar A; Osipov A; Gangi A; Burch M; Waters K; Cho M; Klempner S; Chao J; Kamrava M; Gong J
JAMA Netw Open; 2021 Dec; 4(12):e2138432. PubMed ID: 34889947
[TBL] [Abstract][Full Text] [Related]
23. Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis.
Li Z; Shan F; Wang Y; Zhang Y; Zhang L; Li S; Jia Y; Xue K; Miao R; Li Z; Ji J
PLoS One; 2018; 13(1):e0189294. PubMed ID: 29370182
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant chemotherapy for gastric cancer: a meta-analysis of randomized, controlled trials.
Liao Y; Yang ZL; Peng JS; Xiang J; Wang JP
J Gastroenterol Hepatol; 2013 May; 28(5):777-82. PubMed ID: 23425049
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group.
Ettrich TJ; Berger AW; Perkhofer L; Daum S; König A; Dickhut A; Wittel U; Wille K; Geissler M; Algül H; Gallmeier E; Atzpodien J; Kornmann M; Muche R; Prasnikar N; Tannapfel A; Reinacher-Schick A; Uhl W; Seufferlein T
BMC Cancer; 2018 Dec; 18(1):1298. PubMed ID: 30594153
[TBL] [Abstract][Full Text] [Related]
26. An updated meta-analysis of randomized controlled trial assessing the effect of neoadjuvant chemotherapy in advanced gastric cancer.
Xiong BH; Cheng Y; Ma L; Zhang CQ
Cancer Invest; 2014 Jul; 32(6):272-84. PubMed ID: 24800782
[TBL] [Abstract][Full Text] [Related]
27. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
[No Abstract] [Full Text] [Related]
28. Neoadjuvant chemotherapy for primary resectable pancreatic cancer: a systematic review and meta-analysis.
Ye M; Zhang Q; Chen Y; Fu Q; Li X; Bai X; Liang T
HPB (Oxford); 2020 Jun; 22(6):821-832. PubMed ID: 32001139
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant docetaxel, oxaliplatin and S-1 therapy for the patients with large type 3 or type 4 gastric cancer (OGSG1902): protocol of a multi-center, phase II study.
Endo S; Terazawa T; Goto M; Tanaka R; Kato T; Fujitani K; Kawakami H; Sakai D; Kurokawa Y; Tsujinaka T; Shimokawa T; Satoh T
BMC Cancer; 2022 Jul; 22(1):811. PubMed ID: 35870893
[TBL] [Abstract][Full Text] [Related]
30. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis.
; Paoletti X; Oba K; Burzykowski T; Michiels S; Ohashi Y; Pignon JP; Rougier P; Sakamoto J; Sargent D; Sasako M; Van Cutsem E; Buyse M
JAMA; 2010 May; 303(17):1729-37. PubMed ID: 20442389
[TBL] [Abstract][Full Text] [Related]
31. Survival benefit of neoadjuvant chemotherapy for resectable cancer of the gastric and gastroesophageal junction: a meta-analysis.
Jiang L; Yang KH; Guan QL; Chen Y; Zhao P; Tian JH
J Clin Gastroenterol; 2015; 49(5):387-94. PubMed ID: 25144898
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant chemotherapy with or without radiotherapy versus upfront surgery for resectable pancreatic adenocarcinoma: a meta-analysis of randomized clinical trials.
Ghanem I; Lora D; Herradón N; de Velasco G; Carretero-González A; Jiménez-Varas MÁ; Vázquez de Parga P; Feliu J
ESMO Open; 2022 Jun; 7(3):100485. PubMed ID: 35580504
[TBL] [Abstract][Full Text] [Related]
33. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany].
Bösing NM; Heise JW; Röher HD
Zentralbl Chir; 2000; 125(4):341-7. PubMed ID: 10829314
[TBL] [Abstract][Full Text] [Related]
34. Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America.
Knight G; Earle CC; Cosby R; Coburn N; Youssef Y; Malthaner R; Wong RK;
Gastric Cancer; 2013 Jan; 16(1):28-40. PubMed ID: 22467061
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer.
Rydzewska L; Tierney J; Vale CL; Symonds PR
Cochrane Database Syst Rev; 2010 Jan; (1):CD007406. PubMed ID: 20091632
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant chemotherapy for nonmetastatic esophago-gastric adenocarcinomas: a systematic review and meta-analysis.
Zhang CD; Zeng YJ; Li HW; Zhao ZM; Zhang JK; Dai DQ
Cancer Invest; 2013 Jul; 31(6):421-31. PubMed ID: 23758189
[TBL] [Abstract][Full Text] [Related]
37. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer.
Urschel JD; Vasan H; Blewett CJ
Am J Surg; 2002 Mar; 183(3):274-9. PubMed ID: 11943125
[TBL] [Abstract][Full Text] [Related]
38. Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials.
Mi DH; Li Z; Yang KH; Cao N; Lethaby A; Tian JH; Santesso N; Ma B; Chen YL; Liu YL
Int J Hyperthermia; 2013; 29(2):156-67. PubMed ID: 23418917
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant treatment for stage III and IV cutaneous melanoma.
Gorry C; McCullagh L; O'Donnell H; Barrett S; Schmitz S; Barry M; Curtin K; Beausang E; Barry R; Coyne I
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012974. PubMed ID: 36648215
[TBL] [Abstract][Full Text] [Related]
40. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
